Literature DB >> 26254377

Radiation Therapy for Para-Aortic Lymph Node Metastasis from Uterine Cervical Cancer.

Masaharu Hata1, Etsuko Miyagi2, Izumi Koike3, Reiko Numazaki4, Mikiko Asai-Sato4, Takeo Kasuya3, Hisashi Kaizu3, Yuki Mukai3, Fumiki Hirahara4, Tomio Inoue3.   

Abstract

AIM: To evaluate the efficacy of radiation therapy for para-aortic lymph node metastases from uterine cervical cancer and to identify an optimal radiation regimen. PATIENTS AND METHODS: A total of 80 metastatic para-aortic lymph nodes, ranging from 11-50 mm (median=20 mm) on computed tomography, in 22 patients with squamous cell carcinoma of the uterine cervix were initially treated with radiation therapy. Total radiation doses for para-aortic lymph node metastases were 40-61.2 Gy (median=50.4 Gy) in 1.8-2 Gy fractions.
RESULTS: Eight out of the 22 patients remained alive at a median follow-up of 32 months. Seven irradiated lymph nodes, 20-50 mm in diameter, in four patients progressed after irradiation at total doses of 44-50.4 Gy. No metastatic lymph nodes administered >50.4 Gy (median=55.8 Gy) exhibited progression after irradiation. All metastatic lymph nodes ≤ 25 mm in diameter irradiated with 50 or 50.4 Gy were controlled. The 3-year lymph node progression-free rates were 78% in the cohort of 22 patients and 89% considering all 80 metastatic lymph nodes. Apart from transient hematological reactions, two patients developed grade 3 or more therapy-related toxicities, including radiation proctitis in one and hemorrhagic cystitis and colitis in another.
CONCLUSION: Radiation therapy can effectively control para-aortic lymph node metastases in patients with uterine cervical cancer. A total dose of 50.4 Gy in 1.8 Gy fractions is sufficient to control metastatic lymph nodes ≤ 25 mm in diameter, whereas a higher dose (approximately 55.8 Gy) may be required for larger nodes. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Cervical cancer; para-aortic lymph node metastasis; radiation therapy; squamous cell carcinoma; uterine cervix

Mesh:

Year:  2015        PMID: 26254377

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  1 in total

1.  Locoregional control and survival after lymph node SBRT in oligometastatic disease.

Authors:  Mauro Loi; Michael Frelinghuysen; Natalie Desiree Klass; Esther Oomen-De Hoop; Patrick Vincent Granton; Joachim Aerts; Cornelis Verhoef; Joost Nuyttens
Journal:  Clin Exp Metastasis       Date:  2018-07-11       Impact factor: 5.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.